Views & Analysis GSK and Sanofi CEOs: it's drug prices, stupid How pharma can move on from the recent controversies around pricing is one of the industry's biggest issues.
News GSK plans $800m US manufacturing investment GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.